PDCD1 and pachyonychia congenita: Metastatic spreading of CRPC (mCRPC) still represents the major cause of PC-related death and compounds, such as taxanes, poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitors, and programmed cell death 1 (PD-1) inhibitors, have entered clinical trials [25].